Fundraising FoxSynapsin Pharmaceuticals
Columbia, US · Delaware corporation
Find your way into Synapsin Pharmaceuticals
Sign up to see every warm intro you have to Synapsin Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synapsin Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JD
John Dorsey DenisNamed on SEC filing
MK
MARK KINDYNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$375K disclosed across 1 round · 2016
▶$375KraisedJul 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$375KraisedJul 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John Dorsey DenisExecutive Officer, Director
- MARK KINDYExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $375K
- Minimum investment
- $50K
- Proceeds to insiders
- $120K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Synapsin Pharmaceuticals raised?
- Synapsin Pharmaceuticals has disclosed $375K raised across 1 round.
- Where is Synapsin Pharmaceuticals headquartered?
- Synapsin Pharmaceuticals is headquartered in Columbia, US.